430 related articles for article (PubMed ID: 23868943)
1. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion.
Liehn EA; Kanzler I; Konschalla S; Kroh A; Simsekyilmaz S; Sönmez TT; Bucala R; Bernhagen J; Weber C
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2180-6. PubMed ID: 23868943
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
[TBL] [Abstract][Full Text] [Related]
3. Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction.
Wang J; Tong C; Yan X; Yeung E; Gandavadi S; Hare AA; Du X; Chen Y; Xiong H; Ma C; Leng L; Young LH; Jorgensen WL; Li J; Bucala R
Circulation; 2013 Jul; 128(3):225-36. PubMed ID: 23753877
[TBL] [Abstract][Full Text] [Related]
4. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion.
Qi D; Hu X; Wu X; Merk M; Leng L; Bucala R; Young LH
J Clin Invest; 2009 Dec; 119(12):3807-16. PubMed ID: 19920350
[TBL] [Abstract][Full Text] [Related]
5. Targeted intracellular accumulation of macrophage migration inhibitory factor in the reperfused heart mediates cardioprotection.
Pohl J; Hendgen-Cotta UB; Rammos C; Luedike P; Mull E; Stoppe C; Jülicher K; Lue H; Merx MW; Kelm M; Bernhagen J; Rassaf T
Thromb Haemost; 2016 Jan; 115(1):200-12. PubMed ID: 26310191
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction.
White DA; Su Y; Kanellakis P; Kiriazis H; Morand EF; Bucala R; Dart AM; Gao XM; Du XJ
J Mol Cell Cardiol; 2014 Apr; 69():32-42. PubMed ID: 24508700
[TBL] [Abstract][Full Text] [Related]
7. Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection.
Tarzami ST; Miao W; Mani K; Lopez L; Factor SM; Berman JW; Kitsis RN
Circulation; 2003 Nov; 108(19):2387-92. PubMed ID: 14568904
[TBL] [Abstract][Full Text] [Related]
8. MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms.
Ochi A; Chen D; Schulte W; Leng L; Moeckel N; Piecychna M; Averdunk L; Stoppe C; Bucala R; Moeckel G
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F767-F780. PubMed ID: 28539339
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
Xia W; Zhang F; Xie C; Jiang M; Hou M
Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
[TBL] [Abstract][Full Text] [Related]
10. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor triggers chemotaxis of CD74+CXCR2+ NKT cells in chemically induced IFN-γ-mediated skin inflammation.
Hsieh CY; Chen CL; Lin YS; Yeh TM; Tsai TT; Hong MY; Lin CF
J Immunol; 2014 Oct; 193(7):3693-703. PubMed ID: 25172501
[TBL] [Abstract][Full Text] [Related]
12. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation.
Gao XM; Liu Y; White D; Su Y; Drew BG; Bruce CR; Kiriazis H; Xu Q; Jennings N; Bobik A; Febbraio MA; Kingwell BA; Bucala R; Fingerle-Rowson G; Dart AM; Morand EF; Du XJ
J Mol Cell Cardiol; 2011 Jun; 50(6):991-9. PubMed ID: 21215754
[TBL] [Abstract][Full Text] [Related]
13. Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart.
Ma H; Wang J; Thomas DP; Tong C; Leng L; Wang W; Merk M; Zierow S; Bernhagen J; Ren J; Bucala R; Li J
Circulation; 2010 Jul; 122(3):282-92. PubMed ID: 20606117
[TBL] [Abstract][Full Text] [Related]
14. Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
Sinitski D; Kontos C; Krammer C; Asare Y; Kapurniotu A; Bernhagen J
Thromb Haemost; 2019 Apr; 119(4):553-566. PubMed ID: 30716779
[TBL] [Abstract][Full Text] [Related]
15. MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.
Tilstam PV; Qi D; Leng L; Young L; Bucala R
Expert Opin Ther Targets; 2017 Jul; 21(7):671-683. PubMed ID: 28562118
[TBL] [Abstract][Full Text] [Related]
16. Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.
Xiong C; Huang B; Cun Y; Aghdasi BG; Zhou Y
Clin Orthop Relat Res; 2014 Jun; 472(6):1943-54. PubMed ID: 24569872
[TBL] [Abstract][Full Text] [Related]
17. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
Klasen C; Ohl K; Sternkopf M; Shachar I; Schmitz C; Heussen N; Hobeika E; Levit-Zerdoun E; Tenbrock K; Reth M; Bernhagen J; El Bounkari O
J Immunol; 2014 Jun; 192(11):5273-84. PubMed ID: 24760155
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway.
Ives A; Le Roy D; Théroude C; Bernhagen J; Roger T; Calandra T
FASEB J; 2021 May; 35(5):e21418. PubMed ID: 33774873
[TBL] [Abstract][Full Text] [Related]
19. Impaired Myocardial MIF/AMPK Activation Aggravates Myocardial Ischemia Reperfusion Injury in High-Fat Diet-Induced Obesity.
Meng F; Li D; Song B; Li L
Endocr Metab Immune Disord Drug Targets; 2019; 19(7):1046-1054. PubMed ID: 30914037
[TBL] [Abstract][Full Text] [Related]
20. MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism.
Kraemer S; Lue H; Zernecke A; Kapurniotu A; Andreetto E; Frank R; Lennartz B; Weber C; Bernhagen J
FASEB J; 2011 Mar; 25(3):894-906. PubMed ID: 21106938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
